Participation of Lower and Upper Middle-Income Countries in Clinical Trials Led by High-Income Countries

Rubagumya, Fidel; Hopman, Wilma; Gyawali, Bishal; Mukherji, Deborah; Hammad, Nazik; Pramesh, C.; Zubaryev, Mykola; Eniu, Alexandru; Tsunoda, Audrey; Kutluk, Tezer; Aggarwal, Ajay; Sullivan, Richard; Booth, Christopher

doi:10.1001/jamanetworkopen.2022.27252

Participation of Lower and Upper Middle-Income Countries in Clinical Trials Led by High-Income Countries

Rubagumya F., Hopman W. M., Gyawali B., Mukherji D., Hammad N., Pramesh C. S., ...Daha Fazla

JAMA NETWORK OPEN, cilt.5, sa.8, 2022 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 5 Sayı: 8
Basım Tarihi: 2022
Doi Numarası: 10.1001/jamanetworkopen.2022.27252
Dergi Adı: JAMA NETWORK OPEN
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Hacettepe Üniversitesi Adresli: Evet

Özet

IMPORTANCE Many randomized clinical trials (RCTs) led by high-income countries (HICs) now enroll patients from lower middle-income countries (LMICs) and upper middle-income countries (UMICs). Although enrolling diverse populations promotes research collaborations, there are issues regarding which countries participate in RCTs and how this participation may contribute to global research.